Viewing Study NCT06235216


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT06235216
Status: RECRUITING
Last Update Posted: 2024-11-01
First Post: 2024-01-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sacituzumab govitEcan in THYroid Cancers
Sponsor: Grupo Espanol de Tumores Neuroendocrinos
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module